Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Is Bristol Myers Squibb's Reported Acquisition of Aurinia a Smart Move?
Is Bristol Myers Squibb's Reported Acquisition of Aurinia a Smart Move?
Is Bristol Myers Squibb's Reported Acquisition of Aurinia a Smart Move?
Submitted by
admin
on November 7, 2021 - 10:55pm
Source:
Motley Fool
News Tags:
Bristol Myers Squibb
Aurinia Pharmaceuticals
M&A
Headline:
Is Bristol Myers Squibb's Reported Acquisition of Aurinia a Smart Move?
snippet:
Bloomberg reported that Bristol Myers Squibb wants to buy Aurinia.
A smaller deal appears to be what Bristol wants and could be a good move for the drugmaker.
Targeting small, cancer-focused biotechs might be an even better strategy for Bristol.
Do Not Allow Advertisers to Use My Personal information
